BIOMAT Database Logo BIOMAT Database Logo

Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. 1996

B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Queensland Institute of Medical Research, The Bancroft Centre, Brisbane, Australia. bevK@qimr.edu.au

Persistent Epstein-Barr virus (EBV) infection is primarily controlled by HLA class I-restricted memory cytotoxic T-cell (CTL) responses which can be reactivated in vitro by stimulation of peripheral blood lymphocytes with autologous lymphoblastoid cell lines. During an investigation of a donor infected by both type A and type B EBV, CTL specific for type B EBV were isolated. The CTL were found to recognize an epitope encoded by the EBNA-6B gene. The minimal epitope sequence was identified as QNGALAINTF, corresponding to residues 213 to 222 in the EBNA-6B protein, and presentation of this epitope was shown to be via HLA B62 (B15). This is the first report of the characterization of an epitope that is EBV type B specific. CTL recognizing sequences common to type A and type B EBV were identified as well. A cross-reactive epitope recognized by these CTL was encoded within the EBNA-6 gene of both type A and type B. This minimal sequence for this epitope was LLDFVRFMGV (residues 284 to 293 in both types), and the epitope was restricted through HLA A*0201. This second epitope sequence overlaps with a published EBV B44-restricted epitope (EENLLDFVRF). The implications of these findings are discussed with respect to the design and efficacy of epitope-based vaccines.

UI MeSH Term Description Entries
D007244 Infectious Mononucleosis A common, acute infection usually caused by the Epstein-Barr virus (HERPESVIRUS 4, HUMAN). There is an increase in mononuclear white blood cells and other atypical lymphocytes, generalized lymphadenopathy, splenomegaly, and occasionally hepatomegaly with hepatitis. Glandular Fever,Mononucleosis, Infectious,Fever, Glandular
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D015234 HLA-A Antigens Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Antigens, HLA-A,HLA-A,Antigens, HLA A,HLA A Antigens

Related Publications

B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Cytotoxic T lymphocyte responses to Epstein-Barr virus.
August 1996, Current opinion in immunology,
B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
January 1997, Annual review of immunology,
B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients.
January 1982, Rheumatology international,
B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.
August 1990, Journal of virology,
B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.
December 2004, The Journal of experimental medicine,
B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children.
September 1995, The Journal of infectious diseases,
B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein.
July 1999, Journal of virology,
B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
February 1988, Nature,
B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Epstein-Barr virus-specific cytotoxic T lymphocyte (EBV-CTL) activities in patients with Kawasaki syndrome.
January 1987, Progress in clinical and biological research,
B M Kerr, and N Kienzle, and J M Burrows, and S Cross, and S L Silins, and M Buck, and E M Benson, and B Coupar, and D J Moss, and T B Sculley
Epstein - Barr virus specific cytotoxic T lymphocytes for the treatment of severe epstein-barr virus mucocutaneous ulcer.
April 2020, British journal of haematology,
Copied contents to your clipboard!